Sort
39,280 grants matching “leukemia”
Characterization and targeting of leukemia stem cell metabolism
$477,177Craig T. Jordan · University Of Colorado Denver · R01 · FY2019 · CA
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition
$477,166Kavindra Nath · University Of Pennsylvania · R01 · FY2024 · CA
Clinical, Immunological and Genetic Analyses of ALPS
$477,005Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Virally-induced tumorigenesis controlled by the microbiota
$476,888Tatyana V. Golovkina · University Of Chicago · R01 · FY2020 · CA
Virally-induced tumorigenesis controlled by the microbiota
$476,888Tatyana V. Golovkina · University Of Chicago · R01 · FY2021 · CA
Cellular Transduction with Replication-Competent Retrovirus Vectors
$476,828Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2011 · CA
Elucidate the Role of RNA Editing in Acute T-cell Lymphoblastic Leukemia Initiating Cells
$476,737Qingfei Jiang · University Of California, San Diego · R01 · FY2025 · CA
Mechanism of combined 'epigenetic therapy' in myeloid malignancies
$476,730Steven D Gore · Johns Hopkins University · R01 · FY2008 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$476,677University Of Arizona · U10 · FY2003 · CA
COVID-19 research efforts
$476,661Thomas Waldmann · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
O-Glycosylation of Epidermal Growth Factor-like Motifs
$476,592Robert S. Haltiwanger · University Of Georgia · R01 · FY2019 · GM
Clinical Transplantation Exploiting NK Cell Activity
$476,560Daniel J Weisdorf · University Of Minnesota · P01 · FY2012 · CA
A Multiplatform Approach to Develop ENL-Targeting Molecules as Drug Candidates for Acute Myeloid Leukemia
$476,558Wenshe Ray Liu · Texas A&M University · R01 · FY2024 · CA
Experimental Therapeutics: Clinical Trials Network with Phase I Emphasis
$476,528Mark J Ratain · University Of Chicago · UM1 · FY2015 · CA
Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-
$476,519Laurence J.n. Cooper · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA
Targeting the Epigenome for Lung Cancer Therapy
$476,450David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
HTLV-1 Particle Analysis and Gag Interactions
$476,276Louis M Mansky · University Of Minnesota · R01 · FY2018 · GM
Elucidate the Role of RNA Editing in Acute T-cell Lymphoblastic Leukemia Initiating Cells
$476,234Qingfei Jiang · University Of California, San Diego · R01 · FY2024 · CA
Regulation of Normal and Pathogenic B Cell Proliferation by a c-Myc-initiated Transcription Factor Cascade
$476,096Takeshi Egawa · Washington University · R01 · FY2018 · AI
EPIDEMIOLOGY OF DOWN SYNDROME--LEUKEMIA &DOWN SYNDROME
$476,084University Of Minnesota Twin Cities · R01 · FY2001 · CA
Heme synthesis, use and trafficking during erythropoiesis
$475,997Janis L Abkowitz · University Of Washington · R01 · FY2024 · HL
Flow Cytometric Evaluation of Biomarkers
$475,992Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
$475,941William L. Carroll · New York University School Of Medicine · R01 · FY2021 · CA
In Vivo Detection And Mechanisms of Regulatory B cell Function in Transplantation
$475,939David M Rothstein · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN
$475,929St. Jude Children'S Research Hospital · R01 · FY2003 · CA